Complement component C3b binds directly to purified glycoprotein C of herpes simplex virus types 1 and 2.

Published

Journal Article

Cells infected with herpes simplex virus type 1 (HSV-1), but not HSV-2, express on their surfaces a receptor for the complement component C3b. Receptor activity is markedly enhanced by treatment of the infected cells with neuraminidase. Employing a direct binding assay, consisting of purified HSV glycoproteins immobilized on nitrocellulose and iodinated C3b as a probe, we found that C3b binds directly to gC-1, as well as to gC-2, but not to gB or gD from either serotype. C3b binding was enhanced by treatment of gC-1 or gC-2 with neuraminidase. Endo F or endo H treatment of gC-1 had no effect on C3b binding. However, treatment of gC-2 with these endoglycosidases had a marked negative effect on C3b binding. These results suggest that N-linked oligosaccharides are involved in binding of C3b to gC-2, but not gC-1. Alternatively, removal of N-linked oligosaccharides from gC-2 might adversely affect polypeptide conformation. Glycoprotein C-2 also differs from gC-1 in its effects on the complement cascade. Whereas gC-1 accelerated the decay of the alternative pathway C3 convertase and impaired the efficiency of lysis by the components C5 through C9, gC-2 stabilized the active C3 convertase and had little effect on the late-acting components. The dissimilarity of gC-1 and gC-2 with regard to their effects on the complement cascade may have implications regarding the role of these glycoproteins in confronting the host immune response.

Full Text

Cited Authors

  • Eisenberg, RJ; Ponce de Leon, M; Friedman, HM; Fries, LF; Frank, MM; Hastings, JC; Cohen, GH

Published Date

  • December 1987

Published In

Volume / Issue

  • 3 / 6

Start / End Page

  • 423 - 435

PubMed ID

  • 2849025

Pubmed Central ID

  • 2849025

International Standard Serial Number (ISSN)

  • 0882-4010

Language

  • eng

Conference Location

  • England